Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Phase: Phase 2"
topic_facet:"Lung Neoplasms"
topic_facet:"Recruitment Status: Terminated"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+2%22&filter%5B%5D=topic_facet%3A%22Lung+Neoplasms%22&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Terminated%22&lookfor=%22610%22&type=Subject
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+2%22&filter%5B%5D=topic_facet%3A%22Lung+Neoplasms%22&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Terminated%22&lookfor=%22610%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+2%22&filter%5B%5D=topic_facet%3A%22Lung+Neoplasms%22&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Terminated%22&lookfor=%22610%22&type=Subject
PubPharm (265)
1
Alkotinib Capsule in Patients With ALK-positive Non-small Cell Lung Cancer Previously Treated With Crizotinib : A Phase II, Multicenter, Single-arm Study to Evaluate Safety and Efficacy of Alkotinib Capsule in Patients With ALK-positive Non-small Cell Lung Cancer Previously Treated With Crizotinib
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
2
A Study of Ladiratuzumab Vedotin in Advanced Solid Tumors : Open-Label Phase 2 Study of Ladiratuzumab Vedotin (LV) for Unresectable Locally Advanced or Metastatic Solid Tumors
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
3
LMB-100 Followed by Pembrolizumab in the Treatment of Adults With Mesothelin-Expressing Non-Squamous Non-Small Cell Lung Cancer (NSCLC) : A Phase II Study of LMB-100 Followed by Pembrolizumab in the Treatment of Adults With Mesothelin-Expressing Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
4
Merestinib In Non-Small Cell Lung Cancer And Solid Tumors : A Phase II Study of Merestinib in Non-Small Cell Lung Cancers Harboring MET Exon 14 Mutations and Solid Tumors With NTRK Rearrangements
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
5
A Study of Avelumab in Combination With Axitinib In Non-Small Cell Lung Cancer (NSCLC) or Urothelial Cancer (Javelin Medley VEGF) : A PHASE 2, OPEN LABEL STUDY TO EVALUATE SAFETY AND CLINICAL ACTIVITY OF AVELUMAB (BAVENCIO (REGISTERED)) IN COMBINATION WITH AXITINIB (INLYTA (REGISTERED)) IN PATIENTS WITH ADVANCED OR METASTATIC PREVIOUSLY TREATED NON-SMALL CELL LUNG CANCER OR TREATMENT NAÏVE CISPLATIN-INELIGIBLE UROTHELIAL CANCER JAVELIN MEDLEY VEGF
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
6
Tipifarnib in Advanced Squamous NSCLC With Oncogen HRAS MutAtionS : An Open Label Phase II Study of Tipifarnib in Advanced Squamous Non-small Cell Lung Cancer With HRAS Mutations
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
7
LMB-100 Followed by Pembrolizumab in the Treatment of Adults With Mesothelin-Expressing Non-Squamous Non-Small Cell Lung Cancer (NSCLC) : A Phase II Study of LMB-100 Followed by Pembrolizumab in the Treatment of Adults With Mesothelin-Expressing Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
8
Chemotherapy and Atezolizumab for Patients With Extensive Stage Small Cell Lung Cancer (SCLC) With Untreated, Asymptomatic Brain Metastases : Chemotherapy and Atezolizumab for Patients With Extensive Stage Small Cell Lung Cancer (SCLC) With Untreated, Asymptomatic Brain Metastases
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
9
A Study of PLM60 in Subjects With Relapsed Small-cell Lung Cancer After Platinum-based First-Line Chemotherapy : An Open-label, Multi-center, Phase 2 Study of Liposome-entrapped Mitoxantrone Hydrochloride Injection (PLM60) in Subjects With Relapsed Small-cell Lung Cancer After Platinum-based First-Line Chemotherapy
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
10
Safety and Efficacy of Capmatinib (INC280) Plus Pembrolizumab vs Pembrolizumab Alone in NSCLC With PD-L1≥ 50% : A Randomized, Open Label, Multicenter Phase II Study Evaluating the Efficacy and Safety of Capmatinib (INC280) Plus Pembrolizumab Versus Pembrolizumab Alone as First Line Treatment for Locally Advanced or Metastatic Non-small Cell Lung Cancer With PD-L1≥ 50%
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[27]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Thema: Phase: Phase 2
Filter aufheben
Thema: Lung Neoplasms
Filter aufheben
Thema: Recruitment Status: Terminated
Medienart
265
Aufsätze
265
E-Artikel
265
E-Ressourcen
Zeitschriftentitel
265
ClinicalTrials.gov
Thema
265
610
Lung Neoplasms
Phase: Phase 2
Recruitment Status: Terminated
265
Study Type: Interventional
188
Carcinoma, Non-Small-Cell Lung
43
Small Cell Lung Carcinoma
34
Medical Condition: Lung Cancer
19
Medical Condition: Non-small Cell Lung Cancer
16
Carcinoma
15
Medical Condition: Non Small Cell Lung Cancer
14
Medical Condition: Non-Small Cell Lung Cancer
13
Medical Condition: Small Cell Lung Cancer
9
Neoplasm Metastasis
6
Adenocarcinoma of Lung
5
Adenocarcinoma
5
Brain Neoplasms
5
Medical Condition: Lung Cancer, Metastatic Cancer
5
Neoplasms, Second Primary
4
Medical Condition: Lung Neoplasms
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
98
2020-
157
2010-2019
10
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
265
Englisch
Haven't found what you're looking for?
Wird geladen...